A population-based epidemiologic study of adult neuromuscular disease in the Republic of Ireland
- PMID: 27927941
- DOI: 10.1212/WNL.0000000000003504
A population-based epidemiologic study of adult neuromuscular disease in the Republic of Ireland
Abstract
Objective: To estimate the prevalence rates (PRs) of acquired and inherited neuromuscular diseases (NMD) in the adult Irish population, reflecting the burden of these conditions in a single country.
Methods: This population-based study was performed in the Republic of Ireland (RoI), with a PR estimated for December 2013. Multiple case ascertainment sources were utilized. Demographic and clinical information and relevant diagnostic results were registered.
Results: A total of 2,641 adults were identified, giving a PR of 62.6/100,000 (95% confidence interval [CI] 59.95-65.24) for all NMD in RoI. Disease-specific PR include chronic inflammatory demyelinating polyradiculoneuropathy 5.87/100,000 (95% CI 5.06-6.68), Charcot-Marie-Tooth 10.52/100,000 (95% CI 9.44-11.61), hereditary neuropathy with liability to pressure palsies 0.84/100,000 (95% CI 0.54-1.15), myotonic dystrophy type I 6.75/100,000 (95% CI 5.88-7.61), Duchenne muscular dystrophy 3.0/100,000 (95% CI 2.33-3.70), Becker muscular dystrophy 2.2/100,000 (95% CI 1.64-2.88), facioscapulohumeral dystrophy 2.59/100,000 (95% CI 2.05-3.13), limb-girdle muscular dystrophy 2.88/100,000 (95% CI 2.31-3.45), periodic paralysis 1.72/100,000 (95% CI 1.28-2.15), myotonia congenita 0.32/100,000 (95% CI 0.18-0.56), paramyotonia congenita 0.15/100,000 (95% CI 0.06-0.34), Kennedy disease 0.83/100,000 (95% CI 0.40-1.27), Lambert-Eaton myasthenic syndrome 0.29/100,000 (95% CI 0.11-0.47), myasthenia gravis 15.12/100,000 (95% CI 13.82-16.42), and sporadic inclusion body myositis 11.7/100,000 (95% CI 9.82-13.58). PR for amyotrophic lateral sclerosis was established from an existing Register as 7.20/100,000 (95% CI 6.34-8.15).
Conclusions: The PR of all adult NMD in RoI is relatively high when compared with other chronic neurologic disorders, although some figures may be an underestimate of the true prevalence. The data provide a framework for international comparison and service planning.
© 2016 American Academy of Neurology.
Similar articles
-
The prevalence of hereditary neuromuscular disorders in Northern Norway.Brain Behav. 2021 Jan;11(1):e01948. doi: 10.1002/brb3.1948. Epub 2020 Nov 13. Brain Behav. 2021. PMID: 33185984 Free PMC article.
-
Methodology and design of a national epidemiological study on adult neuromuscular disease.Neuroepidemiology. 2014;43(2):123-30. doi: 10.1159/000367634. Epub 2014 Nov 5. Neuroepidemiology. 2014. PMID: 25376451
-
What we do not know about pregnancy in hereditary neuromuscular disorders.Neuromuscul Disord. 2009 Oct;19(10):675-9. doi: 10.1016/j.nmd.2009.07.004. Epub 2009 Aug 18. Neuromuscul Disord. 2009. PMID: 19692244 Review.
-
Prevalence and incidence of neuromuscular conditions in the UK between 2000 and 2019: A retrospective study using primary care data.PLoS One. 2021 Dec 31;16(12):e0261983. doi: 10.1371/journal.pone.0261983. eCollection 2021. PLoS One. 2021. PMID: 34972157 Free PMC article.
-
Population frequencies of inherited neuromuscular diseases--a world survey.Neuromuscul Disord. 1991;1(1):19-29. doi: 10.1016/0960-8966(91)90039-u. Neuromuscul Disord. 1991. PMID: 1822774 Review.
Cited by
-
Global prevalence of Duchenne and Becker muscular dystrophy: a systematic review and meta-analysis.J Orthop Surg Res. 2022 Feb 15;17(1):96. doi: 10.1186/s13018-022-02996-8. J Orthop Surg Res. 2022. PMID: 35168641 Free PMC article. Review.
-
Epidemiology of the idiopathic inflammatory myopathies.Nat Rev Rheumatol. 2023 Nov;19(11):695-712. doi: 10.1038/s41584-023-01033-0. Epub 2023 Oct 6. Nat Rev Rheumatol. 2023. PMID: 37803078 Review.
-
B cells in the pathophysiology of myasthenia gravis.Muscle Nerve. 2018 Feb;57(2):172-184. doi: 10.1002/mus.25973. Epub 2017 Sep 30. Muscle Nerve. 2018. PMID: 28940642 Free PMC article. Review.
-
Intermediate Charcot-Marie-Tooth disease: an electrophysiological reappraisal and systematic review.J Neurol. 2017 Aug;264(8):1655-1677. doi: 10.1007/s00415-017-8474-3. Epub 2017 Mar 31. J Neurol. 2017. PMID: 28364294 Review.
-
Effects of Natural Products on Neuromuscular Junction.Curr Neuropharmacol. 2022 Mar 4;20(3):594-610. doi: 10.2174/1570159X19666210924092627. Curr Neuropharmacol. 2022. PMID: 34561984 Free PMC article. Review.
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials